West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 225,500 | 199,800 | 235,900 | 269,300 | 226,600 |
| Receivables | 296,700 | 290,400 | 253,200 | 251,800 | 242,400 |
| Inventories | 208,200 | 215,700 | 215,200 | 215,800 | 211,300 |
| Other current assets | 36,500 | 37,600 | 39,200 | 40,000 | 37,500 |
| TOTAL | $766,900 | $743,500 | $743,500 | $776,900 | $717,800 |
| Non-Current Assets | |||||
| PPE Net | 826,700 | 857,800 | 855,000 | 835,400 | 811,800 |
| Investments And Advances | 91,800 | 89,900 | 85,800 | 84,600 | 83,600 |
| Intangibles | 128,300 | 131,600 | 129,400 | 129,600 | 128,700 |
| Other Non-Current Assets | 60,000 | 46,800 | 49,100 | 103,900 | 101,100 |
| TOTAL | $1,106,800 | $1,126,100 | $1,119,300 | $1,153,500 | $1,125,200 |
| Total Assets | $1,873,700 | $1,869,600 | $1,862,800 | $1,930,400 | $1,843,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 126,200 | 127,600 | 138,100 | 121,900 | 130,900 |
| Accrued Expenses | 55,100 | 50,600 | 56,200 | 62,900 | 48,100 |
| Other current liabilities | 88,400 | 71,900 | 79,200 | 74,600 | 73,800 |
| TOTAL | $287,600 | $263,400 | $279,500 | $300,000 | $289,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 196,400 | 198,000 | 197,000 | 196,600 | 195,700 |
| aiOther Non-Current Liabilities | 96,000 | 90,600 | 96,000 | 108,000 | 106,700 |
| TOTAL | $304,200 | $300,900 | $303,400 | $313,500 | $311,600 |
| Total Liabilities | $591,800 | $564,300 | $582,900 | $613,500 | $600,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,538 | 73,578 | 73,987 | 74,253 | 74,002 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,700 | 18,700 |
| Retained earnings | 1,258,000 | 1,222,800 | 1,178,200 | 1,188,600 | 1,148,000 |
| Other shareholders' equity | -143,600 | -95,800 | -117,400 | -130,300 | -151,600 |
| TOTAL | $1,281,900 | $1,305,300 | $1,279,900 | $1,316,900 | $1,242,400 |
| Total Liabilities And Equity | $1,873,700 | $1,869,600 | $1,862,800 | $1,930,400 | $1,843,000 |